Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

Cancer breakthrough reveals old drugs with new tricks may limit spread

Cancer breakthrough reveals old drugs with new tricks may limit spread

Health: low-meat and meat-free diets associated with lower overall cancer risk

Health: low-meat and meat-free diets associated with lower overall cancer risk

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Exercise reduces anxiety during active surveillance for prostate cancer

Exercise reduces anxiety during active surveillance for prostate cancer

Virtual patient ‘surrogates’ can personalise cancer treatments

Virtual patient ‘surrogates’ can personalise cancer treatments

ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic castration-resistant prostate cancer

ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st...

ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer

ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer

ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer

ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer

ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse populations

ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse populations

More from ecancer